Common use of Development Payments Clause in Contracts

Development Payments. 4.1 In consideration of the rights granted to Neurocrine in Article 2, herein, Neurocrine shall pay to DOV a licensing fee of $5,000 upon the execution of this Agreement. 4.2 Neurocrine shall make scheduled payments and issue warrants for the purchase of shares of Neurocrine's capital stock to DOV in the amounts, and at the times, stated below: US $1,300,000 plus warrants to purchase 75,000 shares of Neurocrine common stock, upon commencement of the first Pivotal Trial for the Marketed Product. A warrant to purchase 15,000 shares of Neurocrine common stock shall have an exercise price equal to ---------- [***] Omitted pursuant to a request for confidential treatment. The omitted material has been separately filed with the Securities and Exchange Commission.